Current position:
Research Director (DR2), INSERM
Team leader, "Immune tolerance and T cell differentiation", Center of Immunology Marseille-Luminy (CIML), France
http://www.ciml.univ-mrs.fr/fr/science/lab-magali-irla/immune-tolerance-and-t-cell-differentiation
Contact: Magali.Irla@inserm.fr
Since 2022: Member of the scientific panel "Immunology, Microbiology, Infection" (CSS5), INSERM
Education and academic positions:
2013-2020: Prinicpal Investigator, CR1 INSERM (Marie Curie Reintegration grant, SIGNEPI4TOL); Center of Immunology Marseille-Luminy (CIML), France
Project: "Immunological tolerance: implication of thymic epithelial cells and regulatory T cells"
2016: Habilitation à Diriger des Recherches (HDR)
2010-2012: Junior group leader, Ambizione Fellow (Swiss National Science Foundation) - Department of Pathology and Immunology - University of Geneva Medical School,Switzerland. http://pathology.unige.ch/group- irla.html
Project: “Patterning and homeostasis of the thymic medulla, a microenvironment specialized in T cell tolerance induction”
2006-2010: Postdoctoral fellow (EMBO Long Term fellow), Pr. Walter Reith’s laboratory - Department of Pathology and Immunology - University of Geneva Medical School, Switzerland
Project: “Cellular and molecular mechanisms controlling the cellularity of Aire+ medullary thymic epithelial cells - key mediators of central T cell tolerance”
2001-2005: Ph.D. in Immunology, Dr. Catherine Nguyen’s laboratory - INSERM-U928 - University of Aix-Marseille II, France
Project: “Genomic and functional characterization of a gene expressed by thymic epithelial cells: Spatial”
2001: Master in Immunology, University of Aix-Marseille II
Prizes and Awards:
2019-2022 PEDR - Inserm
2019 Laureate of the French National Academy of Medicine
2015-2019 Marie Curie Career Integration Grant
2014 Installation Award - City of Marseille
2012 Young Investigator Award - International Cytokine Society (ICS)
2011 Young Investigator Award - French Society for Immunology (SFI)
2010 Biogen-Dompé Award - Swiss Multiple Sclerosis Society
2006-2007 EMBO long-term fellowship
2004 Laureate of Innovact Awards for European Innovation
Editorial activities:
- Since 2017: Review Editor, Frontiers in Immunology, “Section Alloimmunity and Transplantation”
- Since 2015: Review Editor, Frontiers in Immunology, “Section Immunological Tolerance and Regulation”
- Since 2013: Associate Editorial Board member, American Journal of Clinical and Experimental Immunology
Magali Irla has a long-standind interest in understanding the mechanisms controlling the induction of T-cell tolerance in the thymus (Annu Rev Immunol 2022). The thymic medulla provides a specialized microenvironment dedicated for T-cell education. In particular, medullary thymic epithelial cells (mTECs) play a central role in this process by their unique capacity to activate a promiscuous gene-expression program leading to the synthesis of a large repertoire of peripheral self-antigens. This gene expression program is controlled by the Autoimmune Regulator (Aire), a transcription factor that is defective in the human disease autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED).
Her work has established that the cellularity of mTECs expressing Aire is controlled by antigen specific interactions with CD4+ thymocytes (Immunity 2008, Trends Immunol 2010). These interactions induce the expansion and patterning of the thymic medulla by regulating the transcriptional and epigenetic profile of mTECs (Elife 2022, Front Immunol. 2015, J Immunol. 2013). In the context of these interactions, her team has shown that the cytokine lymphotoxin α fine-tunes the thymic entry of peripheral dendritic cells and macrophages, which regulates central tolerance (Nat. Commun 2018). Lymphotoxin also acts as an inhibitory checkpoint for the thymic development of Foxp3+ Tregs from the Foxp3lo precursor pathway via IL-4 signaling (Nat. Commun 2024). Moreover, TGF-β signaling in thymocytes is crucial for Aire+ mTEC differentiation and efficient negative selection (Nat. Commun 2019). In a therapeutic perspective, her team has demonstrated the regenerative potential of the cytokine RANKL to restore the thymic function upon bone marrow transplantation (EMBO Mol Med 2017).
Finally, she extended her interest in the field of T-cell tolerance by studying the mechanisms controlling the maintenance of peripheral T-cell tolerance, with a particular emphasis on the role of plamacytoid dendritic cells (pDCs). She found that pDCs, via their ability to present Ags to CD4+ T cells, confer a natural protection against autoimmune disease development and thus can determine the outcome of adaptive immune responses in vivo (J Exp Med. 2010).
Commentaries and previews on published work:
Passos GA, Mendes-da-Cruz DA, Oliveira EH. Editorial: The Role of Aire, microRNAs and Cell–Cell Interactions on Thymic Architecture and Induction of Tolerance. Front Immunol. 2015 Dec 14;6:615.
Bordon Y. Immune tolerance: Present and clear danger. Nat Rev Immunol. 2010 Sep;10(9):616.
Other links:
http://www.ciml.univ-mrs.fr/science/lab-magali-irla/immune-tolerance-and-t-cell-differentiation
https://loop.frontiersin.org/people/83580/impact
https://www.researchgate.net/profile/Magali_Irla
https://orcid.org/0000-0001-8803-9708
https://mobile.twitter.com/irlalab (@IrlaLab)